Annexon (ANNX) Cash from Operations (2019 - 2026)
Annexon's (ANNX) quarterly Cash from Operations came in at 46796000.0 in Q1 2026, up 6.51% year-on-year from 43935434.97 in Q1 2025, and down 1.89% quarter-over-quarter from 45926000.0 in Q4 2025.
Annexon (ANNX) Cash from Operations (2019 - 2026) Analysis & Trends
Annexon's Cash from Operations history runs 8 years deep, the most recent figure standing at 46796000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 6.51% year-over-year to 46796000.0 in Q1 2026; TTM through Mar 2026 was 183097000.0, a 30.98% decrease from a year earlier, with the FY2025 full-year figure at 186356000.0, down 57.92% from the prior year.
- Cash from Operations retreated to 46796000.0 in Q1 2026 per ANNX's latest filing, from 45926000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 21709000.0 in Q2 2024 and bottomed at 52304000.0 in Q3 2025.
- The 5-year median for Cash from Operations is 32015000.0 (2024), against an average of 34624058.82.
- Across the five-year window, Cash from Operations soared 40.33% in 2024 and sank 77.08% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 27139000.0 in 2022, then grew by 13.49% to 23477000.0 in 2023, then tumbled by 53.41% to 36015000.0 in 2024, then dropped by 27.52% to 45926000.0 in 2025, then dropped by 1.89% to 46796000.0 in 2026.
- Per Business Quant, the three latest ANNX Cash from Operations figures stand at 46796000.0 (Q1 2026), 45926000.0 (Q4 2025), and 52304000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - | -46.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.80 Mn |
| Mar 31, 2026 | -46.80 Mn |
| Dec 31, 2025 | -45.93 Mn |
| Dec 31, 2025 | -45.93 Mn |
| Sep 30, 2025 | -52.30 Mn |
| Sep 30, 2025 | -52.30 Mn |
| Jun 30, 2025 | -38.07 Mn |
| Jun 30, 2025 | -38.07 Mn |
| Mar 31, 2025 | -50.06 Mn |
| Mar 31, 2025 | -50.06 Mn |
| Dec 31, 2024 | -36.02 Mn |
| Dec 31, 2024 | -36.02 Mn |
| Sep 30, 2024 | -32.02 Mn |
| Sep 30, 2024 | -32.02 Mn |
| Jun 30, 2024 | -21.71 Mn |
| Jun 30, 2024 | -21.71 Mn |
| Mar 31, 2024 | -28.27 Mn |
| Mar 31, 2024 | -28.27 Mn |
| Dec 31, 2023 | -23.48 Mn |
| Dec 31, 2023 | -23.48 Mn |